Strahlentherapie und Onkologie

Papers
(The median citation count of Strahlentherapie und Onkologie is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Treatment of COVID-19 pneumonia with low-dose radiotherapy plus standard of care versus standard of care alone in frail patients35
Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancer33
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie32
Assoziation von alterstypischen strukturellen Veränderungen des Gehirns und Ganzhirnbestrahlung30
Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients28
Automated contouring for breast cancer radiotherapy in the isocentric lateral decubitus position: a neural network-based solution for enhanced precision and efficiency27
Reply to Letter to the Editor: Reply to comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy27
Assessing the quality of radiation oncology education in four German medical schools: a student perspective and comparison with DEGRO recommendations26
Impact of reduced interval from simulation CT to treatment delivery on dosimetric and positioning accuracy for total marrow lymph-node irradiation24
Stereoscopic X-ray image and thermo-optical surface guidance for breast cancer radiotherapy in deep inspiration breath-hold23
Neoadjuvante Therapie des lokal fortgeschrittenen Plattenepithelkarzinoms des Ösophagus23
Longer time to testosterone recovery impacts favorably on outcomes for prostate cancer following androgen deprivation and radiotherapy22
Neoadjuvante Chemoimmuntherapie gefolgt von einer dosis- und volumenreduzierten Chemoradiotherapie bei lokal fortgeschrittenen Kopf-Hals-Karzinomen21
Dosimetric advantages for cardiac substructures in radiotherapy of esophageal cancer in deep-inspiration breath hold21
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial19
Abnormal visual and olfactory sensations during radiation therapy: a prospective study19
Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie zur Behandlung des NSCLC im Stadium I18
Dosiseskalation bei der Radiotherapie inoperabler Ewing-Tumoren18
Langzeitergebnisse der ORATOR-Studie: Radiotherapie versus transorale roboter-assistierte Chirurgie in der Primärtherapie des Oropharynxkarzinoms18
Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours17
Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma17
Risikostandardisierte Mortalitätsraten übertreffen als Qualitätsindikator die typischen „Mindestzahlen“ in der onkologischen Chirurgie – ein neuer Blick auf Krankenhauszentralisationen mithilfe nation16
The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting16
Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer16
Optimizing energy consumption in radiotherapy: standard vs. hypo-/ultra-hypofractionation and becoming SMART (specific, measurable, achievable in radiotherapy)15
Correction to: Analysis and stress-test of the spatial accessibility to German radiation oncology centers15
26th Annual SASRO Meeting15
Teaching communication skills in medical education15
Comparison of integral doses to normal tissue and organs at risk between interstitial high-dose-rate brachytherapy and modern external-beam radiotherapy techniques in breast and head and neck cancer p14
Synthetic CTs for MRI-only brain RT treatment: integration of immobilization systems14
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer14
Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy14
ACOUNEU – Radiochirurgie oder hypofraktionierte Strahlentherapie beim Vestibularis-Schwannom?13
Can interventional radiotherapy (brachytherapy) be an alternative to surgery in early-stage oral cavity cancer? A systematic review13
Proton therapy in young breast cancer patients with germline TP53 and ATM mutations: a case series13
Radio(chemo)therapy in anaplastic thyroid cancer—high locoregional but low distant control rates—a monocentric analysis of a tertiary referral center13
Intra-adaptational changes in online adaptive radiotherapy: from the ideal to the real dose13
Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal c13
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)13
Stereotaktische Radiotherapie plus Nivolumab bei NSCLC13
Cardiac metastasis in uterine cervical cancer13
Potential Single Nucleotide Polymorphisms markers for radiation dermatitis in head and neck cancer patients: a meta-analysis12
DEGRO 2023 Abstractbuch12
Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center12
Unerwünschte Ereignisse bei Patienten unter Immuntherapie nach Strahlentherapie – gepoolte Analyse von Studien aus der Datenbank der US Food and Drug Administration12
Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients12
Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma11
Genomic analysis of radiosensitivity in breast cancer11
Radio(chemo)therapy in anal cancer: evaluation of sex-specific disparities across AJCC stages11
Impact of dose volume parameters and clinical characteristics on radiation-induced acute oral mucositis for head and neck cancer patients treated with carbon-ion radiotherapy dose volume outcome analy11
German radiation oncology’s next generation: a web-based survey of young biologists, medical physicists, and physicians—from problems to solutions11
Deutsche Gesellschaft für Radioonkologie (DEGRO) mahnt stationäre strahlentherapeutische Versorgung an11
Intensity modulated radiation therapy in prostate cancer—Better survival with higher total dose?11
Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer11
Nintedanib zur Therapie der radiogenen Pneumonitis11
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis10
Determinants of radiation dose to immune cells during breast radiotherapy10
Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature10
Stellenwert einer „targeted therapy“ beim EGFR-mutierten Lungenkarzinom nach erfolgter Radiochemotherapie10
Surface-guided DIBH radiotherapy for left breast cancer: impact of different thresholds on intrafractional motion monitoring and DIBH stability10
Thymic tumors: radiotherapy experience for single institute10
Kein Vorteil einer Erhaltungstherapie mit Afatinib in der adjuvanten Therapie von Kopf-Hals-Tumoren10
Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis10
First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy10
Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature10
Körperstereotaktische Bestrahlung als „Erstlinientherapie“ des oligometastasierten Nierenzellkarzinoms10
Multidisciplinary treatment is necessary in glioblastoma with extracerebral metastases9
Die intraoperative Strahlentherapie (IORT) als mögliche Alternative zum vollständigen Verzicht auf eine adjuvante Radiotherapie nach brusterhaltender Operation bei älteren Patientinnen mit niedriger R9
Correction to: From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer9
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?9
The benefit of intravenous immune globulin in the treatment of delayed radiation myelopathy9
Long-term survival in patients with brain metastases—clinical characterization of a rare scenario9
Isodoses—a set theory-based patient-specific QA measure to compare planned and delivered isodose distributions in photon radiotherapy9
Accelerated vs. conventionally fractionated postoperative radiotherapy of non-small cell lung cancer—final results of the prematurely terminated PORTAF trial9
Multimodale Therapieansätze beim Hochrisikoprostatakarzinom – was wann?9
Neoadjuvant chemoradiotherapy in combination with deep regional hyperthermia followed by surgery for rectal cancer: a systematic review and meta-analysis8
Keine abskopalen Effekte bei Kombination von Immuntherapie und stereotaktischer Radiotherapie bei Merkel-Zell-Karzinomen8
Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays—results of the TARGIT BQR prospective phase IV trial8
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking8
Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy8
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer8
Organerhaltende Behandlung bei nodal-positiven Harnblasenkarzinomen8
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities8
4DCT ventilation function image-based functional lung protection for esophageal cancer radiotherapy8
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma8
Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis8
Phase-II-Studie zur Therapiedeeskalation bei HPV-assoziierten Oropharynxkarzinomen. Kommentar II8
Effect of simultaneous integrated boost concepts on photoneutron and distant out-of-field doses in VMAT for prostate cancer8
Prophylaktische Hirnbestrahlung mit und ohne Hippocampusschonung beim kleinzelligen Bronchialkarzinom (PREMER) – eine randomisierte Phase-III-Studie8
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomy8
CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis8
Olaparib bei biochemischem Rezidiv des High-risk-Prostatakarzinoms nach Prostatektomie8
Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis8
Kein Vorteil für die lokale Kontrolle nach Dosiseskalation der Strahlentherapie bei Patienten mit Ösophaguskarzinom nach einer definitiven Radiochemotherapie: randomisierte Phase-III-Studie ARTDECO8
YB-1 activating cascades as potential targets in KRAS-mutated tumors7
Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapy7
Postoperative Radiotherapie für pT1–2-N0-Zungenkarzinome: Zeit für ein Umdenken?7
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy7
Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up7
Ampelopsis japonica enhances the effect of radiotherapy in non-small cell lung cancer7
Vergleich der radikalen Zystektomie mit der trimodalen Therapie beim muskelinvasiven Harnblasenkarzinom7
Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival7
Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis7
Chemoradiotherapy for untreated Masaoka–Koga stage IVB thymic carcinoma: a single-center retrospective study7
Radiotherapy for painful shoulder syndrome: a retrospective evaluation7
Assessment and validation of glottic motion using cone-beam CT and real-time cine MRI7
Pulmonary artery intimal sarcoma: Case report of a patient managed with multimodality treatment and a comprehensive literature review7
Staphylococcus-aureus-Kolonisation als Risikofaktor der akuten Strahlenreaktion an der Haut7
Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis6
Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients6
Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer6
Sekundärmalignome nach Ganzkörperbestrahlung pädiatrischer Leukämiepatienten – eine kritische Re-Evaluation der multizentrischen ALL-SCT-BFM-2003-Studie6
Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma6
Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Associati6
Postoperative therapy patterns for thymic carcinoma with complete resection: retrospective analysis of 120 patients6
Digital redesign of the radiotherapy course for medical students with a blended learning approach6
High radiation dose in chemoradiotherapy followed by immunotherapy with durvalumab in patients with stage III non-small cell lung cancer does not increase risk for pneumonitis6
Breast cancer related lymphedema and shoulder mobility following radiotherapy6
Mepitel-Film zur Prävention der Radiodermatitis bei Brustbestrahlung6
CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study6
Outcomes of craniospinal radiotherapy in adult medulloblastoma: survival, long-term toxicities, and quality of life assessment with SF-12 and t-Cog6
A new GPU-based Monte Carlo code for helium ion therapy6
FBXL18 increases cell proliferation and reduces cell radiosensitivity in esophageal squamous cell carcinoma6
Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma6
DEGRO 2025 Abstractband6
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway6
Stereotaktische Radiotherapie bei funktionell inoperablem, aber technisch resektablem Pankreaskarzinom6
Application of frozen Thiel-embalmed specimens for radiotherapy delineation guideline development: a method to create accurate MRI-enhanced CT datasets6
Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 study6
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell5
Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors5
The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review5
Influence of chemoradiation on the immune microenvironment of cervical cancer patients5
Ceftriaxone has a neuroprotective effect in a whole-brain irradiation-induced neurotoxicity model by increasing GLT-1 and reducing oxidative stress5
Correction to: Comparison of 3D and 4D Monte Carlo optimization in robotic tracking stereotactic body radiotherapy of lung cancer5
The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients5
Chemotherapiebedingte kognitive Beeinträchtigungen bei Mammakarzinompatientinnen – Risikofaktoren und Therapie5
Pentoxifylline and vitamin E for treating radiation-induced fibrosis in breast and head and neck cancer patients5
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients5
Effect of radiotherapy on the DNA cargo and cellular uptake mechanisms of extracellular vesicles5
Dose–effect relationship between dose–volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center5
Deutlicher Überlebensvorteil durch simultane Radio- und Chemotherapie: Erkenntnisse aus einer chinesischen Phase-III-Studie bei älteren Patienten mit Ösophaguskarzinom5
Radiochirurgie beim Nierenzellkarzinom: Daten der multizentrischen prospektiven FASTRACK II-Studie5
Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences5
Usability and usefulness of (electronic) patient identification systems—A cross-sectional evaluation in German-speaking radiation oncology departments5
From case to care pathway: proactive detection and management of RCI-associated HLH in radiation oncology5
CBCT-based online adaptive radiotherapy of the prostate bed: first clinical experience and comparison to nonadaptive conventional IGRT5
Irradiation alters extracellular vesicle microRNA load in the serum of patients with leukaemia5
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost5
Präoperative Strahlentherapie und Pembrolizumab bei lokalisierten Weichteilsarkomen der Extremitäten: Ergebnisse der multizentrischen, randomisierten SU2C-SARC032-Studie4
CT-based radiomics prediction of complete response after stereotactic body radiation therapy for patients with lung metastases4
Die MIRAGE-Studie (MR-Linac-basierte Körperstereotaxie bei Prostatakarzinomen) – Precision at its best?4
Dosisreduktion der elektiven Lymphabflussbestrahlung bei Kopf-Hals-Karzinomen: bereit für die klinische Routine?4
Tenth anniversary of the Young DEGRO Team Trial—reflecting on the past, shaping the future4
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation4
State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment4
Proton beam therapy versus trans-arterial chemoembolization for BCLC stage B hepatocellular carcinoma—a propensity-matched analysis4
Prognostic significance of the mEPE score in intermediate-risk prostate cancer patients undergoing ultrahypofractionated robotic SBRT4
From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer4
Proton therapy reduces the effective dose to immune cells in breast cancer patients4
Navigating through recent evidence on locoregional breast cancer radiotherapy: an initiative by the scientific association of Swiss radiation oncology4
Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study4
Artificial intelligence for response prediction and personalisation in radiation oncology4
Dosimetric comparison of advanced radiation techniques for scalp-sparing in low-grade gliomas4
Initial needle tracking with the first standalone combined infrared camera – CT system for brachytherapy—analysis of tracking accuracy and uncertainties4
Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery4
In memory of Univ.-Prof. Dr. med. Normann Willich (1946–2024)4
The effect of incidental dose to pelvic nodes in bladder-only irradiation in the era of IMRT: a dosimetric study4
Is model-based dose calculation based on cone-beam computed tomography suitable for adaptive treatment planning in brachytherapy?4
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer4
Ethical considerations of prospective data collection for stereotactic arrhythmia radioablation (STAR): an overview from the STOPSTORM.eu consortium4
Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography4
Sarcopenia in glioblastoma: the imaging we need and what it tells us4
Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice4
Radiotherapie plus Durvalumab beim lokal fortgeschrittenen NSCLC: die DOLPHIN-Studie4
Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome4
DEGRO 2024 Abstractband4
Low doses to the heart in daily practice for treating left-sided breast cancer using accelerated partial-breast irradiation by multicatheter brachytherapy and deep-inspiration breath-hold using a SIB4
Die Rolle der Chemotherapie im Kontext der Bestrahlung beim Nasopharynxkarzinom: Update der MAC-NPC-Netzwerk-Metaanalyse4
Vorasidenib bei niedriggradigen Gliomen – neues Therapieprinzip mit offenen Fragen zu den Langzeitergebnissen4
Diffusion tensor imaging indices as biomarkers for cognitive changes following paediatric radiotherapy: a systematic review and meta-analysis4
From radiation beams to digital streams: social media engagement of German radiotherapy facilities4
Implementing stereotactic arrhythmia radioablation with STOPSTORM.eu consortium support: intermediate results of a prospective Israeli single-institutional trial4
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?4
Role of resting-state functional MRI in detecting brain functional changes following radiotherapy for head and neck cancer: a systematic review and meta-analysis4
Mutagen sensitivity and risk of second cancer in younger adults with head and neck squamous cell cancer: 15-year results3
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study3
Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin3
Biomarkers in prostate cancer: current status and future directions in radiotherapy—statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)3
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review3
Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma3
Analysis of radiation oncology integration within general practitioners’ daily patient care: a cross-sectional survey in Germany3
Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma3
Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating3
Near-maximum rib dose is the most relevant risk factor for ipsilateral spontaneous rib fracture: a dosimetric analysis of breast cancer patients after radiotherapy3
Definitive (chemo)radiotherapy of enteric-type adenocarcinoma of the lung: time to unmask an underrated treatment option?3
Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy3
Bestrahlen oder nicht bestrahlen bei älteren Patientinnen mit Low-Risk-Mammakarzinom? Erkenntnisse aus den 10-Jahres-Daten der PRIME-II-Studie3
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients3
Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma3
Prophylaktische Strahlentherapie bei asymptomatischen Hochrisiko-Knochenmetastasen3
Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention3
Re-irradiation in progressive diffuse infiltrative pontine glioma in children and young adults3
Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses3
Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach3
Role of palliative SBRT in barcelona clinic liver cancer-stage C hepatocellular carcinoma patients3
Strukturelle, prozedurale und personelle Voraussetzung für die Erbringung radioonkologischer und strahlentherapeutischer Leistungen 2023 in Deutschland – ein Positionspapier der Deutschen Gesellschaft3
Bakterielle Dekolonisierung mit Mupirocin-Nasensalbe reduziert schwere orale Radiomukositis bei Nasopharynxkarzinom – Ergebnisse einer randomisierten Phase-III-Studie3
Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO)3
Dosiseskalation mittels Brachytherapie zur Erhöhung der Organerhaltungsrate beim Rektumkarzinom3
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospe3
Consolidative active scanning proton therapy for mediastinal lymphoma: selection criteria, treatment implementation and clinical feasibility3
Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie3
The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy3
Radiotherapy of localized orbital mantle cell lymphoma: a SEER database analysis of long-term outcomes3
Carbon ion radiotherapy optimization techniques for pancreatic cancer: accounting for the effect of bowel gas variation3
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce “Imaging in Stereotactic Radiotherapy”3
Traditional risk factors and nodal yield—still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?3
Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany—the SUFEETUBE project3
Prerequisites for the clinical implementation of a markerless SGRT-only workflow for the treatment of breast cancer patients3
Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas3
Verbesserte Schluckfunktion nach definitiver Radiochemotherapie bei Oro- und Hypopharynxkarzinomen durch Schonung der Musculi constrictores pharyngis3
Mobile applications in radiation oncology—current choices and future potentials3
Dosiseskalation beim Prostatakarzinom: Standarddosis versus Dosiseskalation mit simultan integriertem Boost auf die intraprostatische Tumorformation: Ergebnisse der FLAME-Studie3
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer2
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms2
Kombination stereotaktischer Radiotherapie mit Checkpointinhibitoren: Ergebnisse der CHEERS-Phase-II-Studie2
Efficacy of palliative hemostatic radiotherapy for tumor bleeding and pain relief in locally advanced pelvic gynecological malignancies2
Correction to: The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments2
Letter to the Editor: reply to “Comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy”2
Gute Therapieverträglichkeit und Lebensqualität nach primär organerhaltender Therapie des frühen Rektumkarzinoms: Ergebnisse der TREC-Studie2
HYDRA-Metaanalyse: Hypofraktionierung beim Prostatakarzinom – sind wir am Ziel?2
Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium2
Thyroid avoidance in treatment planning for breast cancer patients irradiated to the supraclavicular nodes2
Professor Dr. Peter Vaupel zum 80. Geburtstag2
Intensity-modulated radiotherapy does not induce volumetric changes of the Bichat fat pad in nasopharyngeal cancer2
The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planning2
Hemophagocytic lymphohistiocytosis induced by radio-chemo-immunotherapy: a case report2
Correction to: Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis2
Research with cancer registry data in radiation oncology—current possibilities and perspectives2
Survey of treatment and care practices in small-cell lung cancer among German radiation oncologists2
Analysis of fetal dose exposure by modern radiation therapy in pregnant patients with supradiaphragmatic Hodgkin lymphoma—a phantom-based simulation2
Correction: Verbesserung der Ernährungssituation von Patienten mit fortgeschrittenem nicht-kleinzelligem Lungenkarzinom (NSCLC) durch Off-label-Medikation2
Einfluss der körperlichen Aktivität vor, während und nach der Chemotherapie auf die kognitive Leistungsfähigkeit bei Patientinnen mit Mammakarzinom: Ergebnisse einer prospektiven US-amerikanischen Stu2
Definitive Radiotherapie versus Radiochemotherapie mit wöchentlich Docetaxel bei Patienten mit Kopf-Hals-Tumoren und Cisplatinunverträglichkeit2
Selective local postoperative radiotherapy for T3–T4 N0 laryngeal cancer2
Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial2
Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie2
Endokavitäre Kontakttherapie vs. EBRT als Boost bei organerhaltender Strahlentherapie von T2–3-Rektumkarzinomen: Ergebnisse der OPERA-Studie2
Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes2
0.12239694595337